Cannabinoid receptor type 1 (CB1R) inhibits hypothalamic leptin signaling via β-arrestin1 in complex with TC-PTP and STAT3
Authors:
Open Access
Abstract
No abstract availableKeywords
Funding Information
- University of California, San Diego
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Semmelweis Egyetem
- Magyar Tudományos Akadémia (NVKP_16-1-2016-0039)
- Nemzeti Kutatási és Technológiai Hivatal
- National Institute on Alcohol Abuse and Alcoholism
- Nemzeti Kutatási Fejlesztési és Innovációs Hivatal (26303/AOELT/2019)
- Nemzeti Kutatási Fejlesztési és Innovációs Hivatal (FK_18/128376)
- Nemzeti Kutatási Fejlesztési és Innovációs Hivatal (NKFI-6/FK_124038)
- National Institutes of Health (FK_ 18/128376)
- National Institutes of Health (GT1-7)
This publication has 74 references indexed in Scilit:
- C911: A Bench-Level Control for Sequence Specific siRNA Off-Target EffectsPLOS ONE, 2012
- Energy Balance and ObesityCirculation, 2012
- Elevated Hypothalamic TCPTP in Obesity Contributes to Cellular Leptin ResistanceCell Metabolism, 2011
- A mTurquoise-Based cAMP Sensor for Both FLIM and Ratiometric Read-Out Has Improved Dynamic RangePLOS ONE, 2011
- Hyperactivation of anandamide synthesis and regulation of cell-cycle progression via cannabinoid type 1 (CB1) receptors in the regenerating liverProceedings of the National Academy of Sciences, 2011
- Leptin receptor signaling: pathways to leptin resistanceFrontiers in Bioscience-Landmark, 2011
- Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesityJournal of Clinical Investigation, 2010
- The Endocannabinoid System as an Emerging Target of PharmacotherapyPharmacological Reviews, 2006
- Real Time Analysis of STAT3 Nucleocytoplasmic ShuttlingJournal of Biological Chemistry, 2004
- Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesityJournal of Clinical Investigation, 2000